C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2006
10/18/2006	EP1711472A1 Mehtod for producing ionic liquids
10/18/2006	EP1711458A1 Method for producing guanidinium salts
10/18/2006	CN1849330A Specific glucocorticosteroid compound having anti-inflammatory activity
10/18/2006	CN1849308A Thiophenylaminoimidazolines
10/18/2006	CN1849303A Novel heteroaryl derivative
10/18/2006	CN1849122A Method of treating cancer using fpt inhibitors and at least two antineoplastic agents
10/18/2006	CN1849118A Nonsedating alpha-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione
10/18/2006	CN1847228A Ozagrel ornithine salt and its injection form
10/18/2006	CN1847201A Amino group-containing chiral ionic liquid and its prepn process and application
10/18/2006	CN1280672C Photosensitive compound, resin and composition
10/18/2006	CN1280314C Method for controlling polymer molecular weight and structure
10/18/2006	CN1280267C Sulfonylaminocarboxylic acids
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/17/2006	US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006	US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS
10/17/2006	CA2339661C Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/17/2006	CA2241856C Agent for prophylaxis and treatment of diabetic complications
10/12/2006	WO2006107923A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases
10/12/2006	WO2006106960A1 Process for producing disulfonyl fluoride compound
10/12/2006	WO2006106778A1 Bcrp/abcg2 inhibitor
10/12/2006	WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors
10/12/2006	US20060229470 Calcium receptor-active molecules
10/12/2006	US20060229457 Method for producing optically active compound
10/12/2006	US20060229456 Diazotizing a blocked 5-amino-1H-imidazole-4-carboxamide; hydrolysis; antitumor agents
10/12/2006	US20060229446 Structural carotenoid analogs for the inhibition and amelioration of disease
10/12/2006	US20060229342 TNF-a production inhibitors
10/12/2006	CA2603304A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases
10/12/2006	CA2602467A1 Bcrp/abcg2 inhibitor
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1710234A1 Malononitrile compound and use thereof
10/11/2006	EP1710232A1 Process for the release of D,L-methionine
10/11/2006	EP1709037A2 Hiv protease inhibiting sulfonamides
10/11/2006	EP1709005A1 High purity butoconazole nitrate with specified particle size and a process for preparation thereof
10/11/2006	EP1708976A1 Distillation of ionic liquids
10/11/2006	EP1708699A1 Modulators of glucocorticoid receptor, ap-1, and/or nf- k .b activity and use thereof
10/11/2006	EP1504022B1 Process for the synthesis of peptide amides by side-chain attachment to a solid phase
10/11/2006	EP1363509B1 Compositions containing creatine and creatinine
10/11/2006	EP1358309B1 Composition and method for bleaching a substrate
10/11/2006	CN1845933A Specific glucocorticosteriod compound having anti-inflamatory activity
10/11/2006	CN1844105A Beta-elemene derivatives containing nitrogen and their preparation method and use
10/11/2006	CN1844104A Polystyrene-supported hydantoin halides and synthesis process and application thereof
10/11/2006	CN1279025C Improved method of preparing secnidazole
10/10/2006	US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases
10/10/2006	CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/10/2006	CA2240196C Process for the preparation of (meth)acrylic acid esters
10/10/2006	CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
10/05/2006	WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006	WO2006104280A1 Prophylactic/therapeutic agent for diabetes
10/05/2006	WO2006103503A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
10/05/2006	WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases
10/05/2006	WO2006007496A3 Mitotic kinesin inhibitors
10/05/2006	WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006	US20060223995 Superhigh purity ionic liquid
10/05/2006	US20060223872 Insecticidal phthalamide derivatives
10/05/2006	US20060223784 Method and compositions for temporarily incapacitating subjects
10/05/2006	US20060222584 Salts comprising cyanoborate anions
10/05/2006	DE102005013967A1 New imidazole or pyrimidine derivatives are bradykinin B1 antagonists used for treating e.g. pain, stroke, peptic ulcers and other inflammatory disorders
10/05/2006	CA2602566A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
10/04/2006	EP1707265A1 Superhigh purity ionic liquid
10/04/2006	EP1706392A2 Pesticidal heterocyclic dihaloallyl compounds
10/04/2006	EP1706389A1 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses
10/04/2006	EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006	EP1027047B1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation
10/04/2006	EP0906091B1 Amidinohydrazones as protease inhibitors
10/04/2006	CN1842520A 1h-imidazole derivatives as cannabinoid receptor modulators
10/04/2006	CN1842517A 芴衍生物 Fluorene derivatives
10/04/2006	CN1842333A Sustained release tablet for oral use
10/04/2006	CN1841571A Fused-salt type oligomer electrolyte and its use
10/04/2006	CN1277824C Piperazine derivatives
10/04/2006	CN1277528C Dyeing composition for kerationous fibres comprising particular dicationic diazo dye
10/03/2006	US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006	US7115769 Catalyzing the alkylation, forming a 2-alkylcysteine derivatives, a chemical intermediates for iron chelating agents
10/03/2006	US7115752 Substituted cyclic compounds
10/03/2006	US7115750 Melanin concentrating hormone antagonist
10/03/2006	US7115748 Reacting vicinal diamine thiocarbonyl compound, then oxidizing intermediate; adrenergic receptor agonists/antagonists
10/03/2006	US7115736 Process for preparing imidazopyran derivatives
10/03/2006	US7115646 Cyclic diamines and derivatives as factor Xa inhibitors
10/03/2006	US7115620 Relaxation of smooth muscle cells and reduce smooth muscle contractility; urinary incontinence; irritable bladder and bowel disease; asthma; hypertension; stroke
10/03/2006	US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
10/03/2006	US7115607 Substituted piperazinyl amides and methods of use
10/03/2006	US7115605 Peptide deformylase inhibitors
10/03/2006	CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them
09/2006
09/28/2006	WO2006102674A2 Diphenylheterocycle cholesterol absorption inhibitors
09/28/2006	WO2006101266A1 Process for production of optically active hydroxymethyl -substituted phenylalanine
09/28/2006	WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/28/2006	WO2006099684A1 Copper complexes
09/28/2006	WO2006099677A1 Metal complexes
09/28/2006	WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/28/2006	WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds
09/28/2006	US20060217568 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
09/28/2006	US20060217561 Synthesis of substituted thiazoline carboxylic acids
09/28/2006	US20060217534 Bis (amino acid) molecular scaffolds
09/28/2006	US20060217420 4-Ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
09/28/2006	CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/27/2006	EP1704143A1 Malononitrile compound as pesticides
09/27/2006	EP1703909A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses

1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 345